ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to present at the J.P Morgan Healthcare Conference
|
|
JamesTas
|
31 |
10K |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
31
|
10K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
|
|
JamesTas
|
42 |
17K |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
42
|
17K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
|
|
JamesTas
|
42 |
17K |
4 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
42
|
17K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
|
|
JamesTas
|
42 |
17K |
8 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
42
|
17K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to present at the J.P Morgan Healthcare Conference
|
|
JamesTas
|
31 |
10K |
5 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
31
|
10K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the small Christmas Pressie ...for YOU!
|
|
JamesTas
|
15 |
5.7K |
5 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
15
|
5.7K
|
5
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Bionomics Announces Pricing of IPO in the US
|
|
JamesTas
|
5 |
2.3K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
5
|
2.3K
|
0
|
|
ASX - By Stock
|
ABB |
Re:
JPM Initiates with AUD6.5 target
|
|
JamesTas
|
19 |
10K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
19
|
10K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Presentation for Investor Webinar
|
|
JamesTas
|
58 |
20K |
6 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
58
|
20K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Presentation for Investor Webinar
|
|
JamesTas
|
58 |
20K |
4 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
58
|
20K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
JamesTas
|
122 |
39K |
2 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
122
|
39K
|
2
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Fast Track Designation for BNC210 in Social Anxiety Disorder
|
|
JamesTas
|
6 |
2.3K |
0 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
6
|
2.3K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
JamesTas
|
122 |
39K |
14 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
122
|
39K
|
14
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Fast Track Designation for BNC210 in Social Anxiety Disorder
|
|
JamesTas
|
6 |
2.3K |
1 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
6
|
2.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
JamesTas
|
122 |
39K |
22 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
122
|
39K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
6 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
6
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
40
|
11K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
JamesTas
|
557 |
159K |
7 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
557
|
159K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
JamesTas
|
557 |
159K |
4 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
557
|
159K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
JamesTas
|
557 |
159K |
14 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
557
|
159K
|
14
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
0 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
1 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
40
|
11K
|
1
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
0 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
40 |
11K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
6 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Trial PAR008 is on ANZCTR
|
|
JamesTas
|
67 |
23K |
4 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
67
|
23K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Trial PAR008 is on ANZCTR
|
|
JamesTas
|
67 |
23K |
5 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
67
|
23K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
9 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
9 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Time for a big pharma deal
|
|
JamesTas
|
23 |
9.2K |
5 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
23
|
9.2K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
JamesTas
|
191 |
75K |
6 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
JamesTas
|
191 |
75K |
3 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
JamesTas
|
191 |
75K |
23 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
150 |
74K |
0 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
150
|
74K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
318 |
136K |
10 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
318
|
136K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
150 |
74K |
7 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
150 |
74K |
15 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
150 |
74K |
4 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Date of Annual General Meeting
|
|
JamesTas
|
14 |
5.1K |
11 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
14
|
5.1K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Date of Annual General Meeting
|
|
JamesTas
|
14 |
5.1K |
13 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
14
|
5.1K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
8 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
ASX - By Stock
|
BNO |
Re:
MODULATE trial results
|
|
JamesTas
|
70 |
18K |
1 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
70
|
18K
|
1
|
|
ASX - By Stock
|
BNO |
Re:
MODULATE trial results
|
|
JamesTas
|
70 |
18K |
0 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
70
|
18K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
MODULATE trial results
|
|
JamesTas
|
70 |
18K |
0 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
70
|
18K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 2 Synovial Fluid Biomarker Study Update
|
|
JamesTas
|
76 |
24K |
25 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
76
|
24K
|
25
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
8 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
Breaking News
|
|
Re:
COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED
|
|
JamesTas
|
98K |
15M |
0 |
25/10/21 |
25/10/21 |
Breaking News
|
98K
|
15M
|
0
|
|
ASX - By Stock
|
BNO |
Re:
MODULATE trial results
|
|
JamesTas
|
70 |
18K |
0 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
70
|
18K
|
0
|
|